Pill Identifier App

N 342 1.25 (Glyburide 1.25 mg)

Pill imprint N 342 1.25 has been identified as Glyburide 1.25 mg.

Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 1.25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for N 342 1.25

Glyburide 1.25 mg N 342 1.25
Glyburide 1.25 mg N 342 1.25 Front
Glyburide 1.25 mg N 342 1.25 Back
Glyburide 1.25 mg N 342 1.25 Front
Glyburide 1.25 mg N 342 1.25 Back
Glyburide 1.25 mg N 342 1.25
Glyburide
Imprint:
N 342
1.25
Strength:
1.25 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-8342
Inactive Ingredients:
microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
silicon dioxide
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63874-0665 Altura Pharmaceuticals Inc (repackager)
67544-0661 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)